top of page
Investing in
Life Science
Innovation​
Our team leverages significant industry and clinical experience to promote advances in pharmaceuticals, biotechnology, medical devices, and diagnostics while driving better access, delivery, and health equity.
About
We partner with biotechnology, medical device, and diagnostic companies in the US and Canada to improve access and delivery.
Indications
We invest primarily in the oncology and cardiovascular sectors, representing 80% of the portfolio, with the remaining allocations to opportunistic investing in other indications.
Social Impact
We invest with the social mission of improving access and delivery, and donate 10% of our fund carry to non-profits in oncology and cardiovascular to support non-profit research.
People
Our team is composed of clinicians, researchers, big pharma executives, and venture capitalists who have successfully built and invested in dozens of life science companies.
bottom of page